| PUSI # | Igoa Oloa | Fa'amatalaga |
| CPD0004 | Ertugliflozin | O le Ertugliflozin, lea e lauiloa foi o le PF-04971729, o se inhibitor malosi ma le filifilia o le sodium-dependent glucose cotransporter 2 ma le fomaʻi mo togafitiga o le maʻisuka ituaiga 2. |
| CPDA0048 | Omarigliptin | Omarigliptin, fa'aigoa MK-3102, ose fa'atosina malosi ma umi ona galue DPP-4 mo togafitiga fa'atasi i vaiaso ta'itasi o le ma'isuka ituaiga 2. |
| CPDA1089 | Retagliptin | O le Retagliptin, lea e taʻua foi o le SP-2086, o le DPP-4 inhibitor e mafai ona faʻaaogaina mo togafitiga o le maʻisuka ituaiga 2. |
| CPDA0088 | Trelagliptin | Trelagliptin, lea e taʻua foi o le SYR-472, o se inhibitor dipeptidyl peptidase-4 (DPP-4) umi e galue o loʻo atiaʻe e Takeda mo togafitiga o le maʻisuka ituaiga 2 (T2D). |
| CPDA2039 | Linagliptin | Linagliptin, lea e lauiloa foi o le BI-1356, o se inhibitor DPP-4 na fausia e Boehringer Ingelheim mo togafitiga o le maʻisuka ituaiga II. |
| CPDA0100 | Sitagliptin | Sitagliptin (INN; na muai faailoaina o MK-0431 ma faʻatau atu i lalo o le igoa tau fefaʻatauaʻiga Januvia) o se vailaʻau faʻamaʻi faʻamaʻi (anti-diabetic drug) o le dipeptidyl peptidase-4 (DPP-4) inhibitor vasega. |
| CPD0854 | LX-4211 | LX-4211 o se inhibitor SGLT2 / 1 lua malosi; Su'ega fa'ama'i suka. |
| CPDA1553 | LX-2761 | LX2761 o se fa'apitonu'u SGLT1 fa'apitonu'u e malosi tele i vitro ma fa'atuai ai le fa'aogaina o le kulukose o le intestinal i totonu o le vivo e fa'aleleia ai le pulea o le glycemic. |
